comparemela.com

Latest Breaking News On - Simulated cell - Page 1 : comparemela.com

Turbine Receives Investment from Accenture

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesSzabolcs nagyMerck co incUnited states global health innovation fundCancer research horizonsSimulated cellOno pharmaceuticalGlobal health innovation fundMassmutual ventures

Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development

Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesPetra jantzerTom lounibosSzabolcs nagyUnited states global health innovation fundCancer research horizonsMerck co incAccenture life sciencesAccenture venturesBusiness wireSimulated cellSimulated cellsAccenture venture project spotlightProject spotlightOno pharmaceuticalGlobal health innovation fund

Accenture Invests In Predictive Simulation Company Turbine

Accenture Invests In Predictive Simulation Company Turbine
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Petra jantzerAccenture life sciencesSimulated cellAccenture venturesIhr portfolio

Accenture Backs Turbine s AI-Powered Platform to Accelerate Drug Discovery

Accenture Ventures makes a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.

Should knowAccenture venturesDrug discoverySimulated cellHidden gemsMore effectivePromising drug targetsPatient selectionEffective combination therapies

Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy

— Companies will co-develop inhibitors of a dark kinase target (NEK1) identified for cancer dependency by Turbine’s Simulated Cell™ platform — LONDON & BUDAPEST, Hungary & NEW YORK (BUSINESS WIRE) Turbine, a company that is building the world’s first predictive simulation.

New yorkUnited statesRayees rahmanDaniel veresMerck co incUnited states global health innovation fundCancer research horizonsDiscovery the companySimulated cellHarmonic discoveryChief scientific officerOno pharmaceuticalGlobal health innovation fundMassmutual venturesSeed financingInnovation endeavors

vimarsana © 2020. All Rights Reserved.